UK NHS approves Wegovy oral pill for obesity treatment by 2028
Resolves: Wegovy oral pill is included in the NHS prescription formulary for obesity treatment by 2028-07-06, enabling NHS-funded prescriptions for eligible patients.
user-generated· regulatory
UK NHS approves Wegovy oral pill for obesity treatment by 2028
Market overview
The NHS is under pressure to expand access to weight-loss medications. The proven efficacy of semaglutide and the availability of an oral formulation will accelerate NHS approval for broader patient eligibility.
regulatory prediction market
- Implied probability (Yes)
- 72%
- Closes
- 2028-07-06
About this prediction
Resolution criteria
Wegovy oral pill is included in the NHS prescription formulary for obesity treatment by 2028-07-06, enabling NHS-funded prescriptions for eligible patients.
Source: user-generated
More regulatory markets
- Crypto billionaire Harborne faces FCA scrutiny over £5m gift — 55% Yes
- Crypto billionaire Harborne will face FCA scrutiny — 60% Yes
- Crypto billionaire Christopher Harborne’s donation triggers FCA inquiry into funding transparency — 70% Yes
- Crypto billionaire Christopher Harborne will face parliamentary scrutiny over £5m gift — 55% Yes
- Harborne crypto holdings face regulatory scrutiny — 60% Yes
- SEC approves at least 2 new Bitcoin ETFs by Q4 2027 — 75% Yes
- SEC approves Kalshi's crypto futures products by 2026-Q3 — 55% Yes
- Iran's central bank bans crypto mining by 2027 Q1 — 85% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…